Minoryx to validate MIN-102 with Series A funding
14 October 2015 | By Victoria White
A Series A funding round of €19.4M will see Minoryx Therapeutics move its lead project MIN-102 to clinical validation for X-linked adrenoleukodystrophy (X-ALD)...